CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
37.11
4.44%
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 21:00

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.12
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023346 %
Charges from full value of position ($-4.44)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001124 %
Charges from full value of position ($0.21)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001124%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 35.59
Open 36.34
1-Year Change 60.44%
Day's Range 36.25 - 37.17
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 14, 2025 35.59 0.54 1.54% 35.05 35.90 34.75
Jan 13, 2025 35.21 -1.04 -2.87% 36.25 36.25 34.33
Jan 10, 2025 35.96 1.92 5.64% 34.04 36.13 34.00
Jan 8, 2025 34.45 0.35 1.03% 34.10 34.47 33.77
Jan 7, 2025 34.17 1.29 3.92% 32.88 34.44 32.88
Jan 6, 2025 33.15 -0.55 -1.63% 33.70 33.91 33.00
Jan 3, 2025 33.92 0.32 0.95% 33.60 34.06 33.60
Jan 2, 2025 33.89 0.49 1.47% 33.40 33.91 33.32
Dec 31, 2024 33.17 -0.58 -1.72% 33.75 34.00 33.17
Dec 30, 2024 33.65 0.23 0.69% 33.42 34.08 33.42
Dec 27, 2024 33.70 -0.07 -0.21% 33.77 34.17 33.59
Dec 26, 2024 33.98 0.38 1.13% 33.60 34.03 33.60
Dec 24, 2024 33.75 0.68 2.06% 33.07 33.84 33.07
Dec 23, 2024 33.41 0.13 0.39% 33.28 33.53 33.04
Dec 20, 2024 33.22 0.01 0.03% 33.21 33.61 33.05
Dec 19, 2024 33.62 0.19 0.57% 33.43 34.06 32.91
Dec 18, 2024 33.59 -0.93 -2.69% 34.52 35.21 33.48
Dec 17, 2024 34.60 -0.68 -1.93% 35.28 35.54 34.20
Dec 16, 2024 36.03 1.27 3.65% 34.76 36.16 34.76
Dec 13, 2024 34.96 0.13 0.37% 34.83 35.01 34.43

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Exelixis Company profile

Exelixis, Inc., a biotechnology company, engages in the discovery, development, and commercialization of new medicines to enhance care and outcomes for people with cancer. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. It also offers COTELLIC tablets, an inhibitor of MEK in combination with vemurafenib for the treatment of patients with BRAF V600E or V600K mutation-positive advanced melanoma in the United States; and in combination with vemurafenib in other territories, including the European Union, Switzerland, Canada, Australia, and Brazil. Exelixis, Inc. has collaboration and license agreements with Ipsen Pharma SAS, Genentech, Inc., GlaxoSmithKline, Bristol-Myers Squibb Company, Sanofi, Merck, and Daiichi Sankyo Company Limited for the development and commercialization of various compounds and programs. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was founded in 1994 and is headquartered in South San Francisco, California.
Industry: Bio Therapeutic Drugs

1851 Harbor Bay Parkway
ALAMEDA
CALIFORNIA 94502
US

People also watch

Gold

2,694.94 Price
+0.640% 1D Chg, %
Long position overnight fee -0.0110%
Short position overnight fee 0.0028%
Overnight fee time 22:00 (UTC)
Spread 0.30

US100

21,253.50 Price
+2.180% 1D Chg, %
Long position overnight fee -0.0233%
Short position overnight fee 0.0011%
Overnight fee time 22:00 (UTC)
Spread 1.8

XRP/USD

2.96 Price
+10.230% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01475

BTC/USD

99,708.30 Price
+3.440% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading